Beta Bionics Announces Participation At Upcoming Investor Conferences
- Members of the Company's management team will present at the Wolfe Research 8th Annual Healthcare Conference on Tuesday, November 10, 2026 at 12:40pm Eastern Time. Members of the Company's management team will present at the Stifel 2026 Healthcare Conference on Wednesday, November 11, 2026 at 8:40am Eastern Time. Members of the Company's management team will attend the Jefferies 2026 Global Healthcare Conference in London and host in-person meetings on Wednesday, November 18 and Thursday, November 19, 2026. Members of the Company's management team will present at the Piper Sandler 38th Annual Healthcare Conference on Wednesday, December 2, 2026 at 12:00pm Eastern Time.
The presentations will be webcast live. The link to the webcasts will be available on the Company's website in the“Investors-Events & Presentations” section at , and will be archived there for future replay following the events.
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. Beta Bionics' proprietary insulin dosing algorithm is the first FDA-cleared algorithm that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit .
Investor Relations:Blake Beber
Head of Investor Relations
... Media and Public Relations:
Felicia Sanborn
Vice President of Marketing
...
Source: Beta Bionics, Inc.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment